Roivant Sciences (ROIV) Insider Trading & Ownership → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free ROIV Stock Alerts $10.94 +0.34 (+3.21%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Roivant Sciences (NASDAQ:ROIV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$58.00 MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$397.42 M Get ROIV Insider Trade Alerts Want to know when executives and insiders are buying or selling Roivant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROIV Insider Buying and Selling by Quarter Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. Roivant Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/9/2024Eric VenkerCOOSell96,950$10.92$1,058,694.00 1/2/2024Vivek RamaswamyMajor ShareholderSell3,000,000$11.05$33,150,000.00 10/5/2023Eric VenkerCOOSell153,027$10.11$1,547,102.97 10/2/2023Eric VenkerCOOSell440,752$10.80$4,760,121.60 10/2/2023Sciences Ltd. RoivantDirectorBuy1,526,316$38.00$58,000,008.00 9/28/2023Keith S ManchesterDirectorSell6,896,144$11.55$79,650,463.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/28/2023Svf Investments (Uk) LtdMajor ShareholderSell10,000,000$12.60$126,000,000.00 9/27/2023Eric VenkerCOOSell500,000$13.02$6,510,000.00 9/8/2023Eric VenkerCOOSell106,430$12.19$1,297,381.70 9/8/2023Rakhi KumarCAOSell99,350$12.18$1,210,083.00 9/6/2023Eric VenkerCOOSell5,926$11.85$70,223.10 9/5/2023Rakhi KumarCAOSell1,724$12.00$20,688.00 9/1/2023Eric VenkerCOOSell14,763$11.90$175,679.70 8/14/2023Eric VenkerCOOSell59,811$11.89$711,152.79 8/3/2023Rakhi KumarCAOSell3,681$12.00$44,172.00 8/2/2023Eric VenkerCOOSell16,397$11.86$194,468.42 8/1/2023Rakhi KumarCAOSell336$12.00$4,032.00 7/31/2023Eric VenkerCOOSell117,372$11.91$1,397,900.52 7/26/2023Eric VenkerCOOSell73,568$10.91$802,626.88 7/24/2023Eric VenkerCOOSell33,081$10.93$361,575.33 7/21/2023Eric VenkerCOOSell181,998$11.13$2,025,637.74 7/18/2023Rakhi KumarCAOSell100$12.00$1,200.00 7/14/2023Rakhi KumarCAOSell535$12.00$6,420.00 6/22/2023Global Investors Lp VikingMajor ShareholderSell13,000,000$9.90$128,700,000.00 6/9/2023Eric VenkerCOOSell299,384$9.91$2,966,895.44 6/9/2023Rakhi KumarCAOSell43,893$9.93$435,857.49 6/7/2023Eric VenkerCOOSell201$9.85$1,979.85 5/23/2023Eric VenkerCOOSell415$9.85$4,087.75 5/8/2023Eric VenkerCOOSell61,206$8.93$546,569.58 5/4/2023Eric VenkerCOOSell88,838$8.30$737,355.40 5/2/2023Eric VenkerCOOSell109,074$8.29$904,223.46 5/2/2023Rakhi KumarCAOSell15,517$8.42$130,653.14 4/28/2023Rakhi KumarCAOSell71,989$8.47$609,746.83 4/27/2023Eric VenkerCOOSell73,514$8.51$625,604.14 4/26/2023Rakhi KumarCAOSell87,830$8.68$762,364.40 (Data available from 1/1/2013 forward) ROIV Insider Trading Activity - Frequently Asked Questions Who is on Roivant Sciences's Insider Roster? The list of insiders at Roivant Sciences includes Eric Venker, Financial Lp Qvt, Global Investors Lp Viking, Keith S Manchester, Matthew Gline, Pharma Technologies Ltd Dexcel, Rakhi Kumar, Richard Pulik, Sciences Ltd. Roivant, Svf Investments (Uk) Ltd, and Vivek Ramaswamy. Learn more on insiders at ROIV. What percentage of Roivant Sciences stock is owned by insiders? 4.60% of Roivant Sciences stock is owned by insiders. Learn more on ROIV's insider holdings. Which Roivant Sciences insiders have been buying company stock? The following insiders have purchased ROIV shares in the last 24 months: Pharma Technologies Ltd Dexcel ($20,033,626.00), and Sciences Ltd. Roivant ($60,500,010.00). How much insider buying is happening at Roivant Sciences? Insiders have purchased a total of 5,951,583 ROIV shares in the last 24 months for a total of $80,533,636.00 bought. Which Roivant Sciences insiders have been selling company stock? The following insiders have sold ROIV shares in the last 24 months: Eric Venker ($28,526,592.47), Financial Lp Qvt ($26,866,384.75), Global Investors Lp Viking ($128,700,000.00), Keith S Manchester ($79,650,463.20), Matthew Gline ($948,322.61), Rakhi Kumar ($3,305,643.55), Richard Pulik ($15,448.96), Svf Investments (Uk) Ltd ($222,000,000.00), and Vivek Ramaswamy ($64,950,000.00). How much insider selling is happening at Roivant Sciences? Insiders have sold a total of 57,937,799 Roivant Sciences shares in the last 24 months for a total of $554,962,855.54 sold. More Insider Trading Tools from MarketBeat Related Companies: IMGN Insider Trading RYZB Insider Trading CRNX Insider Trading BIO Insider Trading PEN Insider Trading HSIC Insider Trading RGEN Insider Trading CHE Insider Trading EHC Insider Trading ITCI Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ROIV) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.